We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
-2.2%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$78.1B
AUM Growth
-$1.98B
(-2.5%)
Cap. Flow
-$7.02B
Cap. Flow
% of AUM
-8.99%
Top 10 Holdings %
Top 10 Hldgs %
28.7%
Holding
1,440
New
63
Increased
853
Reduced
452
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kinross Gold
KGC
|
+$440M |
| 2 |
C.H. Robinson
CHRW
|
+$323M |
| 3 |
Advanced Micro Devices
AMD
|
+$322M |
| 4 |
Tyler Technologies
TYL
|
+$317M |
| 5 |
Merck
MRK
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$11.9B |
| 2 |
NVIDIA
NVDA
|
+$409M |
| 3 |
Autodesk
ADSK
|
+$261M |
| 4 |
Salesforce
CRM
|
+$258M |
| 5 |
Clorox
CLX
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.82% |
| 2 | Materials | 22.17% |
| 3 | Healthcare | 8.64% |
| 4 | Industrials | 7.37% |
| 5 | Financials | 5.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BA.PRA
76
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
$7.86B
| $251M | 0.32% |
+4,123,397
| New | +$233M |
|
77
Emerson Electric
EMR
$83.3B
| $249M | 0.32% |
2,008,081
-1,888,808
| -48% | -$229M |
|
78
Honeywell
HON
$76.7B
| $248M | 0.32% |
1,164,471
-15,971
| -1% | -$3.33M |
|
|
79
Autodesk
ADSK
$49.6B
| $246M | 0.32% |
832,527
-884,840
| -52% | -$261M |
|
80
Compañía de Minas Buenaventura
BVN
$8.09B
| $246M | 0.31% |
21,344,322
-215,556
| -1% | -$2.76M |
|
81
Hecla Mining
HL
$10B
| $241M | 0.31% |
49,141,322
-5,538,729
| -10% | -$33.1M |
|
82
Bio-Rad Laboratories Class A
BIO
$8.74B
| $238M | 0.3% |
723,471
-580,281
| -45% | -$197M |
|
|
SCHW
83
Charles Schwab
SCHW
$181B
| $237M | 0.3% |
3,205,887
-26,849
| -0.8% | -$2.01M |
|
84
Masco
MAS
$14.2B
| $236M | 0.3% |
3,250,400
+299,520
| +10% | +$24M |
|
85
Meta Platforms (Facebook)
META
$1.37T
| $233M | 0.3% |
397,805
-42,216
| -10% | -$24.8M |
|
86
West Pharmaceutical
WST
$23.9B
| $226M | 0.29% |
689,493
+676,167
| +5,074% | +$213M |
|
87
Thermo Fisher Scientific
TMO
$214B
| $218M | 0.28% |
418,365
+68,927
| +20% | +$37.9M |
|
88
ON Semiconductor
ON
$32.6B
| $216M | 0.28% |
3,430,628
-64,428
| -2% | -$4.44M |
|
89
Danaher
DHR
$138B
| $213M | 0.27% |
929,868
+916,513
| +6,863% | +$225M |
|
90
Air Products & Chemicals
APD
$66.8B
| $213M | 0.27% |
733,912
-30,577
| -4% | -$9.6M |
|
91
Eli Lilly
LLY
$1.03T
| $211M | 0.27% |
273,539
+4,070
| +2% | +$3.37M |
|
92
Medtronic
MDT
$110B
| $208M | 0.27% |
2,598,150
+2,476,935
| +2,043% | +$214M |
|
93
Brown-Forman Class B
BF.B
$13.2B
| $207M | 0.27% |
5,457,501
-3,365,013
| -38% | -$148M |
|
94
Northrop Grumman
NOC
$76B
| $207M | 0.27% |
441,400
-2,324
| -0.5% | -$1.17M |
|
95
Starbucks
SBUX
$121B
| $207M | 0.26% |
2,267,033
-37,148
| -2% | -$3.59M |
|
96
Comcast
CMCSA
$84B
| $206M | 0.26% |
5,491,893
-5,752
| -0.1% | -$239K |
|
97
Constellation Brands
STZ
$22.3B
| $204M | 0.26% |
924,274
+876,745
| +1,845% | +$208M |
|
98
Mondelez International
MDLZ
$80.5B
| $204M | 0.26% |
3,411,179
+3,282,937
| +2,560% | +$217M |
|
99
Palantir
PLTR
$293B
| $203M | 0.26% |
2,687,863
+18,022
| +0.7% | +$1.05M |
|
100
IDEX
IEX
$17.3B
| $202M | 0.26% |
965,201
-67,076
| -6% | -$14.7M |
|
Similar funds
VanEck Associates's Q4 2024 Portfolio in Review
As of Q4 2024, VanEck Associates held 1,440 positions worth $78.1B, down 2.5% from $80.1B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
VanEck Associates withdrew a net $7.02B in Q4 2024, closing 54 positions and reducing 452 holdings. Its most notable exit was Bank of New York Mellon, an estimated $9.49M position sold in full.
By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 41% a quarter earlier, followed by Materials and Healthcare.
Against the trend, VanEck Associates opened a new position in Boeing Co 6.00% Series A Preferred Stock worth $251M.
- VanEck Associates's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 4,123,397 shares worth $251M.
- VanEck Associates added most to Kinross Gold in Q4 2024, an estimated $440M increase.
- VanEck Associates's biggest Q4 2024 reduction was Lam Research, cutting an estimated $11.9B.
- VanEck Associates fully exited Bank of New York Mellon in Q4 2024, selling an estimated $9.49M.
- VanEck Associates's ten largest holdings make up 29% of its $78.1B portfolio in Q4 2024.
- VanEck Associates opened 63 new positions and closed 54 in Q4 2024.
- VanEck Associates's portfolio value fell 2.5% quarter-over-quarter to $78.1B.
Based on VanEck Associates's 13F filing for Q4 2024, filed 29 Jan 2025.